{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:19:48Z","timestamp":1772558388698,"version":"3.50.1"},"posted":{"date-parts":[[2026,2,20]]},"group-title":"Epidemiology","reference-count":26,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T00:00:00Z","timestamp":1771545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,2,20]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background and Aims<\/jats:title>\n                  <jats:p>The glucagon-like peptide-1 receptor agonist (GLP-1 RA) semaglutide has demonstrated efficacy for the secondary prevention of cardiovascular disease among patients with overweight\/obesity without diabetes mellitus. However, the comparative effectiveness of GLP-1 RA versus other antiobesity medications (e.g. phentermine-topiramate) not been evaluated.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>\n                    This was a retrospective, observational, cohort study using target trial emulation methodology using the Truveta electronic health record database of more than 120 million patients. Adult patients with a body mass index (BMI) &gt;=27 kg\/m\n                    <jats:sup>2<\/jats:sup>\n                    , a history of cardiovascular disease (prior ischemic stroke, transient ischemic attack, or myocardial infarction, or known coronary artery disease, heart failure, or peripheral artery disease) without diabetes mellitus were included in the study. The primary endpoint was time to first major adverse cardiovascular or cerebrovascular event (MACCE, defined as stroke or myocardial infarction).\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In total, 35,240 were included in the bupropion-naltrexone versus GLP-1 RA comparison, and 27,051 were included in the phentermine-topiramate versus GLP-1 RA comparison. In the pre-weighting cohort, GLP-1 RA use was associated with decreased hazard of MACCE compared to bupropion-naltrexone (HR 0.50 [95% confidence interval (CI) 0.36-0.69]) and phentermine-topiramate (HR 0.43 [95% CI 0.30-0.60]). In the propensity score-overlap weighted cohort, GLP-1 RA prescription was not associated with a lower hazard of MACCE than bupropion-naltrexone (aHR 0.69 [95% CI 0.47-1.00]) but was associated with a lower hazard compared to phentermine-topiramate (aHR 0.61 [95% CI 0.41-0.91]; adjusted absolute rate difference 0.98 per 1000 person-years).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Prescription of a GLP-1 RA was associated with a lower risk of subsequent MACCE than phentermine-topiramate.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.02.18.26346594","type":"posted-content","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:40:11Z","timestamp":1771609211000},"source":"Crossref","is-referenced-by-count":0,"title":["Secondary Prevention of Cardiovascular Events in Patients with Overweight\/Obesity in Routine Clinical Practice"],"prefix":"10.64898","author":[{"given":"Wenxin","family":"Guo","sequence":"first","affiliation":[{"name":"Duke University, Department of Statistical Science"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maidou","family":"Wang","sequence":"additional","affiliation":[{"name":"Duke University, Trinity College of Arts and Sciences"},{"name":"Duke University, Pratt School of Engineering"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiwon","family":"Shin","sequence":"additional","affiliation":[{"name":"Duke University, Rhodes Information Initiative"},{"name":"Duke University Observational Research Building Interdisciplinary Therapeutic Advances (ORBIT) Hub"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0390-3673","authenticated-orcid":false,"given":"Fan","family":"Li","sequence":"additional","affiliation":[{"name":"Duke University, Department of Statistical Science"},{"name":"Duke University Observational Research Building Interdisciplinary Therapeutic Advances (ORBIT) Hub"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8257-7561","authenticated-orcid":false,"given":"Emily C.","family":"O\u2019Brien","sequence":"additional","affiliation":[{"name":"Duke University Observational Research Building Interdisciplinary Therapeutic Advances (ORBIT) Hub"},{"name":"Duke University, Department of Population Health Sciences"},{"name":"Duke Clinical Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7721-8169","authenticated-orcid":false,"given":"L\u00e1Shaunt\u00e1","family":"Glover","sequence":"additional","affiliation":[{"name":"Duke University, Department of Population Health Sciences"},{"name":"Duke Clinical Research Institute"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristina","family":"Bortfeld","sequence":"additional","affiliation":[{"name":"University of North Carolina- Chapel Hill Department of Family Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anqi","family":"Zhao","sequence":"additional","affiliation":[{"name":"Duke University Observational Research Building Interdisciplinary Therapeutic Advances (ORBIT) Hub"},{"name":"Duke University Fuqua School of Business (on leave)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"McDevitt","sequence":"additional","affiliation":[{"name":"Duke University Observational Research Building Interdisciplinary Therapeutic Advances (ORBIT) Hub"},{"name":"Duke University Fuqua School of Business (on leave)"},{"name":"Washington University Olin School of Business"},{"name":"Washington University School of Public Health"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5770-2088","authenticated-orcid":false,"given":"Cheryl","family":"Kalapura","sequence":"additional","affiliation":[{"name":"Duke University, Department of Population Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Wu","sequence":"additional","affiliation":[{"name":"Duke University, Department of Statistical Science"},{"name":"Duke University, Trinity College of Arts and Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahar","family":"Shibeika","sequence":"additional","affiliation":[{"name":"Duke University, Department of Population Health Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shannon","family":"Aymes","sequence":"additional","affiliation":[{"name":"University of North Carolina- Chapel Hill Department of Family Medicine"},{"name":"University of North Carolina- Chapel Hill Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Porter","sequence":"additional","affiliation":[{"name":"University of North Carolina- Chapel Hill Department of Internal Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Mac Grory","sequence":"additional","affiliation":[{"name":"Duke University Observational Research Building Interdisciplinary Therapeutic Advances (ORBIT) Hub"},{"name":"Duke Clinical Research Institute"},{"name":"Duke University Department of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5728-8872","authenticated-orcid":false,"given":"Jay B.","family":"Lusk","sequence":"additional","affiliation":[{"name":"Duke University Observational Research Building Interdisciplinary Therapeutic Advances (ORBIT) Hub"},{"name":"University of North Carolina- Chapel Hill Department of Internal Medicine"},{"name":"Duke University Department of Neurology"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026030308150726000_2026.02.18.26346594v1.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2307563"},{"key":"2026030308150726000_2026.02.18.26346594v1.2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.1558"},{"key":"2026030308150726000_2026.02.18.26346594v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.obpill.2023.100071"},{"key":"2026030308150726000_2026.02.18.26346594v1.4","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S445415"},{"key":"2026030308150726000_2026.02.18.26346594v1.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.numecd.2023.03.012"},{"key":"2026030308150726000_2026.02.18.26346594v1.6","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2024.2525"},{"key":"2026030308150726000_2026.02.18.26346594v1.7","doi-asserted-by":"publisher","DOI":"10.4178\/epih.e2024001"},{"key":"2026030308150726000_2026.02.18.26346594v1.8","doi-asserted-by":"publisher","DOI":"10.1093\/aje\/kwy201"},{"key":"2026030308150726000_2026.02.18.26346594v1.9","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.7819"},{"key":"2026030308150726000_2026.02.18.26346594v1.10","doi-asserted-by":"publisher","DOI":"10.18637\/jss.v045.i03"},{"key":"2026030308150726000_2026.02.18.26346594v1.11","unstructured":"Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association | Circulation. Accessed March 24, 2025. https:\/\/www.ahajournals.org\/doi\/10.1161\/CIR.0000000000000973"},{"key":"2026030308150726000_2026.02.18.26346594v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-024-01931-z"},{"key":"2026030308150726000_2026.02.18.26346594v1.13","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00672"},{"key":"2026030308150726000_2026.02.18.26346594v1.14","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.40286"},{"key":"2026030308150726000_2026.02.18.26346594v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(16)30006-4"},{"key":"2026030308150726000_2026.02.18.26346594v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2011.94"},{"key":"2026030308150726000_2026.02.18.26346594v1.17","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000000145"},{"key":"2026030308150726000_2026.02.18.26346594v1.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2019.12.049"},{"key":"2026030308150726000_2026.02.18.26346594v1.19","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15269"},{"key":"2026030308150726000_2026.02.18.26346594v1.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.3073"},{"key":"2026030308150726000_2026.02.18.26346594v1.21","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2410819"},{"key":"2026030308150726000_2026.02.18.26346594v1.22","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-0491"},{"key":"2026030308150726000_2026.02.18.26346594v1.23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.57349"},{"key":"2026030308150726000_2026.02.18.26346594v1.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2023.09.014"},{"key":"2026030308150726000_2026.02.18.26346594v1.25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ahj.2024.05.007","article-title":"Cardiovascular event reduction among a US population eligible for semaglutide per the SELECT trial","volume":"276","year":"2024","journal-title":"Am Heart J"},{"key":"2026030308150726000_2026.02.18.26346594v1.26","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2024.5586"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.02.18.26346594","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:15:19Z","timestamp":1772554519000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.02.18.26346594"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,20]]},"references-count":26,"URL":"https:\/\/doi.org\/10.64898\/2026.02.18.26346594","relation":{},"subject":[],"published":{"date-parts":[[2026,2,20]]},"subtype":"preprint"}}